Palau vs Saint Vincent and the Grenadines: Tuberculosis cases
Palau
5 cases
in 2024
Saint Vincent and the Grenadines
5 cases
in 2024
Palau rank
190th
Saint Vincent and the Grenadines rank
190th
Tuberculosis cases over time
- Palau
- Saint Vincent and the Grenadines
How they compare
Palau currently reports 5 cases against 5 cases in Saint Vincent and the Grenadines, a difference of 0 cases.
The two have swapped places 10 times across 25 shared years of data; in 2000 it was Saint Vincent and the Grenadines ahead.
Palau ranks 190th and Saint Vincent and the Grenadines ranks 190th of 215 countries.
Palau has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Palau | Saint Vincent and the Grenadines | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 11.4 cases | 11.1 cases | 0.3 cases | Palau |
| 2010s | 13.7 cases | 9.5 cases | 4.2 cases | Palau |
| 2020s | 9 cases | 6.4 cases | 2.6 cases | Palau |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher tuberculosis cases, Palau or Saint Vincent and the Grenadines?
- Palau, at 5 cases against 5 cases in Saint Vincent and the Grenadines as of 2024.
- What is the difference in tuberculosis cases between Palau and Saint Vincent and the Grenadines?
- 0 cases, with Palau ahead.
- How many years of comparable data are there for Palau and Saint Vincent and the Grenadines?
- 25 years are reported by both, from 2000 to 2024.
- How do Palau and Saint Vincent and the Grenadines rank globally for tuberculosis cases?
- Palau ranks 190th and Saint Vincent and the Grenadines ranks 190th of 215 countries.
- Where does this data come from?
- WHO (2025) β with minor processing by Our World in Data, published as Tuberculosis cases. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The estimated number of new and relapse tuberculosis cases arising in a given year. All forms of the disease are included, including cases in people living with HIV.